Vibliome Therapeutics

0 followers


Vibliome Therapeutics, LLC, has developed a novel systematic approach that enables the design of small molecule kinase inhibitors with unique selectivity profiles and extraordinary selectivity.

Industries

Headquarters

Stage

Employees

Links

Org chart

Robert Goodwin

Collapse
Gary A. Flynn
Co-Founder
Kirk Stevens
VP, Head of Medicinal Chemistry
Patrick Green
Director, Information Technology
Doug Werner
Senior Scientist And Alliance Manager Of Medicinal Chemistry